deCODE genetics clinical trials
Acquired by Amgen, Dec 10, 2012 · source ↗
The registry lists 1 studies whose lead sponsor is deCODE genetics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 29, 2006.
Before and after it joined Amgen
- First submitted before deCODE genetics became part of Amgen
- 1
- First submitted after deCODE genetics became part of Amgen
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- deCODE genetics1 study
Something wrong with this grouping? Tell us on the Amgen page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Amgen studies →
- Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable AnginaSuspendedNCT00353067Phase 3
Sponsor listed in the registry: deCODE genetics · First submitted before deCODE genetics became part of Amgen